NCT04425655: A reported trial by University of California, San Diego
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT04425655 |
|---|---|
| Title | A Phase II Trial of Fludarabine in Combination With Daunorubicin and Cytarabine Liposome for Adults With Newly-diagnosed Acute Myeloid Leukemia: University of California Hematologic Malignancies Consortium Protocol 1914 |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Aug. 5, 2020 |
| Completion date | July 1, 2022 |
| Required reporting date | July 1, 2023, midnight |
| Actual reporting date | June 30, 2023 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | None |